Skip to main content
. 2024 Jan 4;14(6):100932. doi: 10.1016/j.jpha.2023.12.022

Fig. 5.

Fig. 5

Mussel oligosaccharide (MOS-1) reduced triglyceride levels in high-fat HepG2 cells. (A) Confocal imaging of high-fat model cells treated with the noted concentrations of unlabeled MOS-1 for 12 h: Lyso-Tracker Red (LTR, red) and lipid droplets dyes (Lipi-Blue; blue). (B) Area and particle diameter analyses of lipid droplets and lysosome in untreated and MOS-1-treated HepG2 cells (n = 30). (C) Counts of lipid droplets (left) and lysosomes (right) per cell in untreated cells and cells treated with different concentrations of MOS-1 (n = 8). (D) Triglyceride (TG) levels in untreated cells and cells treated with different concentrations of MOS-1 for 12 h (n = 3). ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001; n.s.: no statistically significant.